In this blog, we take a look at ClaretBio’s app note on using Horizon’s cfDNA reference standards in the development of their novel sample prep kit.
6 result(s)
Learn how to examine your NGS data to investigate false positives and negatives, and potential downstream applications
Horizonの汎用される標準サンプルの全エクソームシーケンスデータがご利用可能となりました。この新しい製品情報が、遺伝子診断法の開発をどのようにサポートできるかについて説明しています。
Acute Myeloid Leukaemia (AML) is a group of blood cancer malignancies that originate from the uncontrolled proliferation of blast cells in the bone marrow and circulating blood1. AML is a relatively rare disorder - representing less than 1% of total cancer cases.
See from a real example how Horizon's reference standards can be used to validate a new NGS assay technology.
Top ten recommendations to validate your NGS assay.